Defense Health Agency Contracting Activity - DHACA

Description

The LCRP Early Detection Clinical Consortium Award mechanism is being offered for the first time in Fiscal Year 2010. The intent of the award is to fund clinical studies focused on characterizing, developing, and/or improving early detection modalities for lung cancer. The award is designed to bring together populations of military beneficiaries at high risk for developing lung cancer and lung cancer patients from the specified military treatment facilities (MTFs) listed in Section B.2 with the patient populations and research expertise of highly qualified civilian scientists at outstanding organizations. At the time of award completion, it is anticipated that the recipient will have established a strong infrastructure for an early detection program in order to continue clinical studies that will lead to improved patient outcomes. Projects should be militarily relevant, have well defined objectives, should control for confounders, have a patient population that will provide a sample size of sufficient statistical power, and be capable of producing results that are likely to change clinical practice for early detection of lung cancer. Studies involving non-military patient populations must describe how they pertain to the targeted population (i.e. Armed Forces and/or the US veteran population). Studies proposed for this multi-institutional consortium effort can include small randomized or pilot clinical trials as well as large, randomized clinical trials. All projects shall be limited to clinical research and clinical trials. Animal studies are excluded from consideration.

Who can apply

• Unrestricted

Contact

PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil <br/>eReceipt HELP: 301-682-5507; help@cdmrp.org <br/>
cdmrp.pa@amedd.army.mil